Inhibitory effect of a serine protease inhibitor, FOY-305 on the invasion and metastasis of human pancreatic cancers

International Journal of Oncology

Volumn 11, Issue 4, 1997, Pages 813-817

  Ohta, Tetsuo ^a   Futagami, Fumio ^a   Tajima, Hidehiro ^a   Kitagawa, Hirohisa ^a   Kayahara, Masato ^a   Nagakawa, Takukazu ^a   Miwa, Koichi ^a   Yamamoto, Miyuki ^a   Iseki, Shoichi ^a   Nakanuma, Yasuni ^a   Terada, Tadashi ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Capan 1 pancreatic cancer cell line; FOY 305; Serine protease; Serine protease inhibitor

Indexed keywords

SERINE PROTEINASE INHIBITOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER INVASION; CASE REPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER METASTASIS; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; NUDE MOUSE; ORAL DRUG ADMINISTRATION; PANCREAS CANCER; PRIORITY JOURNAL;

EID: 12644287542     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.11.4.813     Document Type: Article

References (21)

1. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM and Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67-68, 1980.
2. Nakajima M, Welch D, Belloni PN and Nicolson GL: Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 47: 4869-4876, 1987.
3. Sloane BF: Cathepsin B and cystatins: evidence for a role in cancer progression. Semin Cancer Biol 1: 137-152, 1990.
4. Nakajima M, Morikawa K, Fabra A, Bucana CD and Fidler IJ: Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst 82: 1890-1898, 1991.
5. Mignatti P, Robbins E and Rifkin D: Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47: 487-498, 1986.
6. Murphy G, Atkinson S, Ward R, Garziloric J and Reynolds JJ: The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann NY Acad Sci 667: 1-12, 1992.
7. Roth J, Bendayan M and Orci L: Ultrastructural localization of intracellular antigens by the use of protein A-gold complex. J Histochem Cytochem 26: 1074-1081, 1978.
8. Koivunen E, Ristimaki A, Itkonen O, Osman S, Vuento M and Stenman UH: Tumor-associated trypsin participates in cancer cell-mediated degradation of extracellular matrix. Cancer Res 51: 2107-2112, 1991.
9. Koivunen E, Saksela O, Itkonen O, Osman S, Huhtala ML and Stenman UH: Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogen. Int J Cancer 47: 592-596, 1991.
10. Koshikawa N, Yasumitsu H, Umeda M and Miyazaki K: Multiple secretion of matrix serine proteinases by human gastric carcinoma cell lines. Cancer Res 52: 5046-5053, 1992.
11. Ohta T, Terada T, Nagakawa T, Tajima H, Itoh H, Fonseca L and Miyazaki I: Pancreatic trypsinogen and cathepsin B in human pancreatic carcinomas and associated metastatic lesions. Br J Cancer 69: 152-156, 1994.
12. Ohta T, Terada T, Nagakawa T, Kayahara M, Nishimura G, Tsukioka Y, Taniguchi K, Miyazaki I, Numata M, Yamamoto M, Iseki S and Kanno M: Expression of pancreatic trypsinogen in human extrapancreatic gastrointestinal carcinomas. Oncol Rep 1: 759-764, 1994.
13. Hirahara F, Miyagi Y, Miyagi E, Yasumitsu H, Koshikawa N, Nagashima Y, Kitamura H, Minaguchi H, Umeda M and Miyazaki K: Trypsinogen expression in human ovarian carcinomas. Int J Cancer 63: 176-181, 1995.
14. Real FX: The cell biology of pancreatic cancer: an overview. In: Pancreatic Cancer: Molecular and Clinical Advances. Neoptolemos JP and Lemoine NR (eds). Blackwell Science, Oxford, pp3-17, 1996.
15. Oikawa T, Kusuhara M, Ishikawa S, Hitomi J, Kondo A, Iwanaga T and Yamaguchi K: Production of endothelin-1 and thrombomodulin by human pancreatic cancer cells. Br J Cancer 69: 1059-1064, 1994.
16. Miszczuk-Jamska B, Merten M, Guy-Crotte O, Amouric M, Clemente F, Schoumacher RA and Figarella C: Characterization of trypsinogens 1 and 2 in two human pancreatic adenocarcinoma cell lines; CFPAC-1 and CAPAN-1. FEES Lett 294: 175-178, 1991.
17. 1 esterase. Biochim Biophys Acta 484: 417-422, 1977.
18. Carmichael J, Degraff WG, Gadzar AF, Minna JD and Mitchell JB: Evaluation of tetrazolium-based semi-automated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-941, 1987.
19. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245, 1987.
20. Ohkoshi M and Fujii S: Effect of the synthetic protease inhibitor N,N-dimethylcarbamoylmethyl 4-(4-guanidin obenzoyloxy)-phenylacetate methanesulfate on carcinogenesis by 3-methylcholanthrene in mouse skin. J Natl Cancer Inst 71: 1053-1057, 1983.
21. Vezeridis MP, Doremus CM, Tibbetts LM, Tzanakakis GN and Meitner PA: Experimental metastases from a human pancreatic adenocarcinoma in athymic mice. Surg Res Commun 6: 313-319, 1989.